Balo Andrew K has filed 5 insider transactions across 1 company since March 2025.
Most recent transaction: a grant/award of 75 shares of Glucotrack, Inc. ($GCTK) on March 25, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 25, 2025 | Glucotrack, Inc. | $GCTK | Balo Andrew K | Director | A | Common Stock, par value $0.001 per share | 75 | $0.00 | 75.0000 | 0 | 9999.99% | 0.00% |
| July 11, 2025 | Glucotrack, Inc. | $GCTK | Balo Andrew K | Director | A | Common Stock, par value $0.001 per share | 3332 | $0.00 | 3,407.0000 | 25,585,853 | 4442.67% | 0.01% |
| Oct. 3, 2025 | Glucotrack, Inc. | $GCTK | Balo Andrew K | Director | A | Common Stock, par value $0.001 per share | 1285 | $0.00 | 4,692.0000 | 25,585,853 | 37.72% | 0.01% |
| Oct. 3, 2025 | Glucotrack, Inc. | $GCTK | Balo Andrew K | Director | A | Stock option (right to buy) | 4055 | $0.00 | 4,055.0000 | 25,585,853 | 9999.99% | 0.02% |
| March 26, 2025 | Glucotrack, Inc. | $GCTK | Balo Andrew K | Director | A | Common Stock, par value $0.001 per share | 4490 | $0.00 | 4,490.0000 | 0 | 9999.99% | 0.00% |